CA2781875A1 - Peptide reagents and method for inhibiting autoantibody antigen binding - Google Patents

Peptide reagents and method for inhibiting autoantibody antigen binding Download PDF

Info

Publication number
CA2781875A1
CA2781875A1 CA2781875A CA2781875A CA2781875A1 CA 2781875 A1 CA2781875 A1 CA 2781875A1 CA 2781875 A CA2781875 A CA 2781875A CA 2781875 A CA2781875 A CA 2781875A CA 2781875 A1 CA2781875 A1 CA 2781875A1
Authority
CA
Canada
Prior art keywords
oxidase
leu
ala
glu
lys
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2781875A
Other languages
English (en)
French (fr)
Inventor
Maciej Adamczyk
Roy Jeffrey Brashear
Phillip G. Mattingly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of CA2781875A1 publication Critical patent/CA2781875A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
CA2781875A 2009-12-03 2010-11-17 Peptide reagents and method for inhibiting autoantibody antigen binding Abandoned CA2781875A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12/630,671 US20110136141A1 (en) 2009-12-03 2009-12-03 Peptide reagents and method for inhibiting autoantibody antigen binding
US12/630,671 2009-12-03
PCT/US2010/056943 WO2011068676A1 (en) 2009-12-03 2010-11-17 Peptide reagents and method for inhibiting autoantibody antigen binding

Publications (1)

Publication Number Publication Date
CA2781875A1 true CA2781875A1 (en) 2011-06-09

Family

ID=43302561

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2781875A Abandoned CA2781875A1 (en) 2009-12-03 2010-11-17 Peptide reagents and method for inhibiting autoantibody antigen binding

Country Status (5)

Country Link
US (1) US20110136141A1 (https=)
EP (1) EP2507626A1 (https=)
JP (1) JP2013513107A (https=)
CA (1) CA2781875A1 (https=)
WO (1) WO2011068676A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1951281B1 (en) 2005-10-17 2015-04-15 Sloan Kettering Institute For Cancer Research Wt1 hla class ii-binding peptides and compositions and methods comprising same
WO2007120673A2 (en) 2006-04-10 2007-10-25 Sloan Kettering Institute For Cancer Research Immunogenic wt-1 peptides and methods of use thereof
AU2013207669C1 (en) 2012-01-13 2018-05-31 Memorial Sloan Kettering Cancer Center Immunogenic WT-1 peptides and methods of use thereof
US10815273B2 (en) 2013-01-15 2020-10-27 Memorial Sloan Kettering Cancer Center Immunogenic WT-1 peptides and methods of use thereof
RS61173B1 (sr) 2013-01-15 2021-01-29 Memorial Sloan Kettering Cancer Center Imunogeni wt-1 peptidi i postupci za njihovu upotrebu
WO2016048388A1 (en) 2014-09-26 2016-03-31 Somalogic, Inc. Cardiovascular risk event prediction and uses thereof
SMT202200370T1 (it) 2015-11-20 2022-11-18 Memorial Sloan Kettering Cancer Center Composizione per il trattamento del cancro
GB2566516A (en) 2017-09-15 2019-03-20 Univ Oxford Innovation Ltd Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria
CN111077323A (zh) * 2020-01-12 2020-04-28 天津市宝坻区人民医院 消除胰岛素自身抗体干扰的胰岛素测定试剂盒
CN113621018B (zh) * 2021-08-17 2023-06-09 大连理工大学 一种生物大分子偶联物及其制备方法和用途
IT202100023357A1 (it) * 2021-09-09 2023-03-09 Cheirontech S R L Peptidi con attività anti-angiogenica
CN118439981A (zh) * 2024-05-07 2024-08-06 浙江大学 一种氟磺酸类化合物及其应用

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US425651A (en) 1890-04-15 bland
US662147A (en) 1899-12-26 1900-11-20 Jacob Felbel Type-writing machine.
NL154598B (nl) * 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) * 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US3939350A (en) * 1974-04-29 1976-02-17 Board Of Trustees Of The Leland Stanford Junior University Fluorescent immunoassay employing total reflection for activation
US3996345A (en) * 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4275149A (en) * 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4277437A (en) * 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
DE3750503T2 (de) 1986-10-22 1995-02-09 Abbott Lab Chemilumineszierende Acridinium- und Phenantridiniumsalze.
US5006309A (en) 1988-04-22 1991-04-09 Abbott Laboratories Immunoassay device with liquid transfer between wells by washing
US5244630A (en) * 1988-04-22 1993-09-14 Abbott Laboratories Device for performing solid-phase diagnostic assay
US5089424A (en) 1988-06-14 1992-02-18 Abbott Laboratories Method and apparatus for heterogeneous chemiluminescence assay
US5241070A (en) * 1988-09-26 1993-08-31 Ciba Corning Diagnostics Corp. Nucleophilic polysubstituted aryl acridinium esters and uses thereof
US5063081A (en) * 1988-11-14 1991-11-05 I-Stat Corporation Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor
ATE109194T1 (de) 1989-04-14 1994-08-15 Procedes Petroliers Petrochim Verfahren zum dampfkracken von kohlenwasserstoffen.
FR2729759A1 (fr) * 1995-01-19 1996-07-26 Pasteur Sanofi Diagnostics Procede de dosage ultrasensible de la troponine i cardiaque
US5873699A (en) * 1996-06-27 1999-02-23 United Technologies Corporation Discontinuously reinforced aluminum gas turbine guide vane
US6682648B1 (en) * 1997-08-12 2004-01-27 University Of Southern California Electrochemical reporter system for detecting analytical immunoassay and molecular biology procedures
CA2333875C (en) * 1998-06-01 2005-10-11 Roche Diagnostics Corporation Redox reversible bipyridyl osmium complex conjugates
JP2000214167A (ja) * 1999-01-28 2000-08-04 Igaku Seibutsugaku Kenkyusho:Kk 自己抗体検出用試薬及び検出方法
WO2001038873A2 (en) * 1999-11-24 2001-05-31 Biotronic Technologies, Inc. Devices and methods for detecting analytes using electrosensor having capture reagent
FR2810739B1 (fr) * 2000-06-26 2007-01-26 Centre Nat Rech Scient Immunodosage electrochimiques a l'aide de marqueurs metalliques colloidaux
US6887714B2 (en) * 2000-10-16 2005-05-03 Board Of Trustees Of The University Of Arkansas, N.A. Microvolume immunoabsorbant assays with amplified electrochemical detection
US7419821B2 (en) * 2002-03-05 2008-09-02 I-Stat Corporation Apparatus and methods for analyte measurement and immunoassay
US20040018577A1 (en) * 2002-07-29 2004-01-29 Emerson Campbell John Lewis Multiple hybrid immunoassay
FI20030652A0 (fi) * 2003-04-30 2003-04-30 Susann Eriksson Parannettu immunomääritys
US7682833B2 (en) * 2003-09-10 2010-03-23 Abbott Point Of Care Inc. Immunoassay device with improved sample closure
US7723099B2 (en) * 2003-09-10 2010-05-25 Abbott Point Of Care Inc. Immunoassay device with immuno-reference electrode
JP4197180B2 (ja) * 2005-06-29 2008-12-17 株式会社シバヤギ 検体中の内分泌物質測定方法
US7776605B2 (en) * 2006-10-26 2010-08-17 Abbott Laboratories Assay for cardiac troponin autoantibodies
EP2097750A2 (en) * 2006-10-26 2009-09-09 Abbott Laboratories Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
CA2669863A1 (en) * 2006-12-22 2008-07-03 Abbott Laboratories Cardiovascular autoimmune disease panel and methods of using same
US7906293B2 (en) * 2007-04-09 2011-03-15 Abbott Laboratories Acridinium phenyl esters useful in the analysis of biological
US20090162876A1 (en) * 2007-12-20 2009-06-25 Abbott Laboratories Myeloperoxidase assays

Also Published As

Publication number Publication date
JP2013513107A (ja) 2013-04-18
US20110136141A1 (en) 2011-06-09
WO2011068676A1 (en) 2011-06-09
EP2507626A1 (en) 2012-10-10

Similar Documents

Publication Publication Date Title
US8304201B2 (en) Autoantibody enhanced immunoassays and kits
US20110136141A1 (en) Peptide reagents and method for inhibiting autoantibody antigen binding
US8652788B2 (en) Assay for diagnosis of cardiac myocyte damage
US8835120B2 (en) Assay for cardiac troponin-T (cTnT)
US8357495B2 (en) Immunoassay of analytes in samples containing endogenous anti-analyte antibodies
US9435797B2 (en) Detection of autoantibodies reactive with pancreatic islet cell antigenic molecules and/or insulin
US10107826B2 (en) Immunoassay methods and reagents for decreasing nonspecific binding
US10641768B2 (en) Methods and kits for decreasing interferences from leukocytes in specific binding assays
WO2020010009A1 (en) Direct immunoassay measurement of autoantibodies
US20120238037A1 (en) Immunological assay and immunological assay kit
WO2008070460A2 (en) The use of soluble e-cadherin as a novel serum marker
WO1999001477A1 (en) Method for diagnosing systemic lupus erythematosus
KR20200061691A (ko) 표적 물질 검출 키트
JP2024030655A (ja) リンパ球性下垂体前葉炎及び副腎皮質刺激ホルモン単独欠損症の検査のための試薬及び検査方法
JPH05501919A (ja) リウマチ因子の検出用の混合免疫グロブリン

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20151117